EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Vycor Medical's enterprise value is $3.79 Mil.
Vycor Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $1.46 Mil. Therefore, Vycor Medical's EV-to-Revenue for today is 2.60.
The historical rank and industry rank for Vycor Medical's EV-to-Revenue or its related term are showing as below:
VYCO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.83 Med: 3.83 Max: 23.57
Current: 2.6
During the past 13 years, the highest EV-to-Revenue of Vycor Medical was 23.57. The lowest was 0.83. And the median was 3.83.
VYCO's EV-to-Revenue is ranked better than 57.26% of 826
companies
in the Medical Devices & Instruments industry
Industry Median: 3.265
vs VYCO: 2.60
As of today (2024-05-11), Vycor Medical's stock price is $0.084.
Vycor Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.04. Therefore, Vycor Medical's PS Ratio for today is 2.00.
Vycor Medical EV-to-Revenue Historical Data
The historical data trend for Vycor Medical's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vycor Medical's EV-to-Revenue
For the Medical Devices subindustry, Vycor Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vycor Medical's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Vycor Medical's EV-to-Revenue falls into.
Vycor Medical's current Enterprise Value is $3.79 Mil.
Vycor Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical (OTCPK:VYCO) EV-to-Revenue Explanation
Vycor Medical's share price for today is $0.084.
Vycor Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Vycor Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Vycor Medical (Vycor Medical) Business Description
Vycor Medical Inc is engaged in designing, developing and marketing medical devices for use in neurosurgery in the United States. It has developed ViewSite Brain Access System, which helps to reduce brain tissue trauma that arises from excessive pressure at the edges of the blade. It also provides non-invasive rehabilitation therapies for patients having disorders resulting from neurological brain damage caused by a stroke. The company operates through two segments: Vycor Medical, which focuses on devices for neurosurgery; and NovaVision, which focuses on neurostimulation therapies and diagnostic devices for the treatment and screening of visual field loss. The majority of the revenue comes from the Vycor Medical segment in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VYCO has been successfully added to your 